| Tissue Repair in Stem Cell Transplant Recipients (NCT00501228) | M.D. Anderson Cancer Center | 2003-02-01 |
| Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer (NCT00265837) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2002-12-01 |
| Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder (NCT00054340) | Fred Hutchinson Cancer Center | 2002-10-01 |
| Recombinant Human Keratinocyte Growth Factor in Unrelated and Related Transplants (NCT00056875) | University of Michigan | 2002-09-01 |
| Tacrolimus, Sirolimus and Methotrexate as Graft Versus Host Disease Prophylaxis After Blood Stem Cell Transplantation (NCT00146614) | Dana-Farber Cancer Institute | 2002-07-01 |
| Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer (NCT00255710) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2002-07-01 |
| Safety and Efficacy Study of Photopheresis With UVADEX to Prevent Graft-versus-Host Disease (NCT00054600) | Mallinckrodt | 2002-06-01 |
| Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia (NCT00053157) | Roswell Park Cancer Institute | 2002-06-01 |
| Safety and Efficacy Study of Photopheresis Plus Standard Therapy to Treat Chronic Graft-versus-Host Disease (NCT00054613) | Mallinckrodt | 2002-06-01 |
| Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease (NCT00031824) | Children's Oncology Group | 2002-04-01 |
| Beclomethasone Plus Prednisone in Treating Patients With Graft-Versus-Host Disease (NCT00043147) | Memorial Sloan Kettering Cancer Center | 2002-04-01 |
| Sirolimus as Secondary Therapy in Chronic Graft-Versus-Host Disease Not Responding To Prior Treatment (NCT00079183) | Fred Hutchinson Cancer Center | 2002-04-01 |
| Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders (NCT00544115) | City of Hope Medical Center | 2001-10-16 |
| Study of Allogeneic Bone Marrow and T-Cell Depleted, CD34+ Peripheral Blood Stem Cell Transplantation in Patients With Aplastic Anemia (NCT00017654) | Northwestern Memorial Hospital | 2001-04-01 |
| Methylprednisolone With or Without Daclizumab in Treating Patients With Acute Graft-Versus-Host Disease (NCT00053976) | Dana-Farber Cancer Institute | 2001-01-01 |
| Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer (NCT00014469) | Memorial Sloan Kettering Cancer Center | 2000-12-01 |
| Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma (NCT00006747) | Alliance for Clinical Trials in Oncology | 2000-11-01 |
| Allogeneic Transplantation From Related Haploidentical Donors (NCT00185692) | Stanford University | 2000-08-01 |
| Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon (NCT00010283) | Fred Hutchinson Cancer Center | 2000-07-01 |
| Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases (NCT00006055) | Fairview University Medical Center | 2000-03-01 |
| Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies (NCT00006054) | Fairview University Medical Center | 2000-03-01 |
| Pilot Study of Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Life Threatening Hemophagocytic Disorders (NCT00006056) | Fairview University Medical Center | 2000-03-01 |
| Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous Therapy (NCT00005988) | Dana-Farber Cancer Institute | 2000-02-01 |
| Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer (NCT00004232) | Northwestern University | 1999-10-01 |
| Stem Cell Transplantation in Treating Patients With Hematologic Cancer (NCT00004904) | Northwestern University | 1999-10-01 |
| Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer (NCT00290628) | Masonic Cancer Center, University of Minnesota | 1999-10-01 |
| Study of MEDI 507 in the Treatment of Pediatric Patients (NCT00813618) | MedImmune LLC | 1999-09-01 |
| Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant (NCT00003894) | Roswell Park Cancer Institute | 1999-03-01 |
| Trial for Evaluation of Safety of Escalating Dose Levels of MEDI-507 in Patients for Treatment of at Least Grade II Graft-Versus-Host Disease (GvHD) (NCT00806208) | MedImmune LLC | 1999-01-01 |
| Bone Marrow Transplantation in Treating Patients With Hematologic Cancer (NCT00003398) | University of Maryland, Baltimore | 1998-09-01 |
| Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases (NCT00003662) | Roswell Park Cancer Institute | 1998-08-01 |
| Study of the Pharmacokinetics of Mycophenolate Mofetil in Patients Who Have Undergone Orthotopic Liver Transplantation (NCT00007059) | National Center for Research Resources (NCRR) | 1998-06-01 |
| Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer (NCT00003661) | Roswell Park Cancer Institute | 1998-06-01 |
| Study of MEDI-507 in With Steroid-Resistant Acute Graft-Versus-Host Disease (NCT00806728) | MedImmune LLC | 1998-05-01 |
| Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer (NCT00003335) | Case Comprehensive Cancer Center | 1998-01-01 |
| Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease (NCT00003414) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1997-10-01 |
| Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer (NCT00003270) | Roswell Park Cancer Institute | 1997-09-04 |
| Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation (NCT00005641) | H. Lee Moffitt Cancer Center and Research Institute | 1997-09-01 |
| Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation (NCT00003056) | Baxalta now part of Shire | 1997-04-01 |
| Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow Transplant (NCT00005852) | H. Lee Moffitt Cancer Center and Research Institute | 1996-06-01 |
| Bone Marrow Transplantation in Treating Patients With Leukemia (NCT00006451) | Masonic Cancer Center, University of Minnesota | 1996-04-01 |
| Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives (NCT00001529) | National Heart, Lung, and Blood Institute (NHLBI) | 1996-03-18 |
| Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow Transplant (NCT00002790) | Fred Hutchinson Cancer Center | 1996-03-01 |
| Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia (NCT00002833) | M.D. Anderson Cancer Center | 1994-10-01 |
| Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation (NCT00002456) | Fred Hutchinson Cancer Center | 1986-05-01 |
| Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia (NCT00004878) | Jonsson Comprehensive Cancer Center | |
| Early Access Program Using Alpha 1 Antitrypsin Infusion for Patients With Steroid Refractory Acute GvHD After Hematopoietic Stem Cell Transplantation (HSCT) (NCT03172455) | Impatients N.V. trading as myTomorrows | |
| Prochymal Expanded Access Treatment for Pediatric Patients Who Have Failed Steroids for Acute GVHD (NCT00759018) | Mesoblast, Inc. | |
| Fludarabine in Treating Patients With Steroid-Resistant Chronic Graft- Versus-Host Disease (NCT00004194) | Jonsson Comprehensive Cancer Center | |
| Prochymal® Expanded Access for Adults Who Have Failed Steroid Treatment for Acute Graft Versus Host Disease (GVHD) (NCT00826046) | Mesoblast, Inc. | |
| OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies (NCT00081055) | Mesoblast International Sàrl | |
| A Study to Assess Efficacy, Safety and Pharmacokinetics of a Tacrolimus New Oral Formulation (MR4) in BMT Recipients (NCT00189761) | Astellas Pharma Inc | |